KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gartner (IT) Total Liabilities (2016 - 2026)

Gartner filings provide 18 years of Total Liabilities readings, the most recent being $7.6 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 8.74% to $7.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.6 billion, a 8.74% increase, with the full-year FY2025 number at $7.8 billion, up 8.22% from a year prior.
  • Total Liabilities hit $7.6 billion in Q1 2026 for Gartner, down from $7.8 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $7.8 billion in Q4 2025 to a low of $6.6 billion in Q3 2022.
  • Median Total Liabilities over the past 5 years was $6.9 billion (2022), compared with a mean of $7.0 billion.
  • Biggest five-year swings in Total Liabilities: rose 13.58% in 2022 and later fell 1.3% in 2025.
  • Gartner's Total Liabilities stood at $7.1 billion in 2022, then increased by 1.18% to $7.2 billion in 2023, then grew by 0.28% to $7.2 billion in 2024, then increased by 8.22% to $7.8 billion in 2025, then fell by 2.24% to $7.6 billion in 2026.
  • The last three reported values for Total Liabilities were $7.6 billion (Q1 2026), $7.8 billion (Q4 2025), and $6.7 billion (Q3 2025) per Business Quant data.